Demant A/S (WILYY)
OTCMKTS
· Delayed Price · Currency is USD
17.78
0.00 (0.00%)
At close: Apr 28, 2025
Demant Revenue
In the year 2024, Demant had annual revenue of 22.42B DKK with 3.79% growth. Demant had revenue of 11.33B in the half year ending December 31, 2024, with 11.01% growth.
Revenue
22.42B DKK
Revenue Growth
+3.79%
P/S Ratio
2.58
Revenue / Employee
990.28K DKK
Employees
22,639
Market Cap
8.03B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.42B | 818.00M | 3.79% |
| Dec 31, 2023 | 21.60B | 1.90B | 9.62% |
| Dec 31, 2022 | 19.71B | 1.80B | 10.05% |
| Dec 31, 2021 | 17.91B | 3.44B | 23.75% |
| Dec 31, 2020 | 14.47B | -477.00M | -3.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Demant News
- 3 months ago - Demant A/S (WILLF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Demant A/S (WILLF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Demant A/S (WILLF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Demant A/S (WILLF) Q2 2023 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Demant A/S (WILLF) Q3 2023 Earnings Call Transcript - Seeking Alpha
- 3 years ago - The Scandinavian Shopping List In A Time Of Bargains - Seeking Alpha